Clinical trials and Haemophilia during the COVID-19 pandemic: Madrid's experience

Haemophilia. 2020 Sep;26(5):e247-e249. doi: 10.1111/hae.14055. Epub 2020 Jun 12.

Authors

Maria Teresa Álvarez-Román¹, Sara García-Barcenilla¹, Tamara Cebanu¹, Elena González-Zorrilla¹, Nora V Butta¹, Ihosvany Fernandez-Bello¹, Monica Martín-Salces¹, Maria Isabel Rivas-Pollmar¹, Victor Jiménez-Yuste²

Affiliations

¹ Unit of Thrombosis and Hemostasis, Hematology Department, La Paz University Hospital, IdiPAZ. Madrid, Madrid, Spain.
² Unit of Thrombosis and Hemostasis, Hematology Service, La Paz University Hospital, IdiPAZ. Autonomous University. Madrid, Madrid, Spain.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 / epidemiology
COVID-19 / prevention & control*
COVID-19 / virology
Clinical Trials as Topic / methods*
Delivery of Health Care / methods
Delivery of Health Care / trends
Hemophilia A / therapy*
Humans
Pandemics
SARS-CoV-2 / physiology
Spain / epidemiology
Telemedicine / methods*